Copay Assistance From The Assistance Fund Now Available for Eligible People Living With Heart Failure

The NIVA|HF investigational algorithm uses proprietary venous waveform technology from VoluMetrix to assess otherwise hard-to-obtain cardiovascular metrics. According to study authors, 'This non-invasive measurement has potential for … prevention of hospital admission in heart failure patients.'

NIVA|HF is an investigational device designed to monitor the venous waveform, a novel physiologic signal, in heart failure patients. As a Breakthrough Device, NIVA|HF will receive pre-market developmental assistance and prioritized regulatory review from FDA. NIVA|HF is the first application of VoluMetrix's proprietary venous waveform technology.

In Vitro Assay Accelerates Drug Development in Human-Relevant Heart Models

In Vitro Approach Provides Predictive Platform for Human-Based Drug Discovery

Demonstrates platform's ability to engineer mature human cardiac tissue and generate models of human heart disease starting from patient iPSCs

Gladstone scientists identify genes that enable adult cells to divide and multiply

Gladstone scientists show that a cancer drug is effective in treating common causes of heart failure

Rod Carew, former Minnesota Twins, Los Angeles Angles of Anaheim, and heart failure survivor teams up with The American Heart Association in an effort to improve the treatment outcomes and the overall experience of heart failure patients.

Healthy Heart's medical director, Dr. Suresh Gadasalli, says the painless treatment has reduced or eliminated angina pain, fatigue, and shortness of breath for hundreds of the center's patients

Dr. Scott Fertels says non-invasive treatment boosts blood flow to the heart, relieves chest pain, and improves energy and mobility for about 80 percent of patients with symptomatic coronary artery disease

Painless outpatient treatment boosts blood flow to the heart, stops chest pain, restores energy and ability to exercise, and can reduce need for medication says Dr. Thomas Pelz, Director of BAHC's Cardiac Rehabilitation Program

New, Non-invasive Outpatient Procedure for Treating Heart Disease Available at the Office of Dr. Don W. Lee Improves Vascular Health and can Reduce Symptoms Associated with Coronary Artery Disease for Three to Five Years

Dr. Ola Akinboboye of Laurelton Heart Specialists says studies suggest EECP® treatments may also improve sexual function in coronary artery disease patients with erectile dysfunction

Cardiologist Charles W. Abbottsmith, MD, of Ohio Heart and Vascular Center Says Many Heart Patients with Chest Pain, Fatigue and Shortness of Breath are able to Discard Wheelchairs and Walk after Series of Painless One-hour EECP® Treatments

Katy Spink, Vice President of Operations for Geron, will give the Featured presentation at GTCbio's 6th Stem Cell Research & Therapeutics Conference, May 27-28, 2010 in Boston, MA.

Author Lon Maisttison launches a website for his heart failure books titled: "Kissed by Death: Congestive Heart Failure", "Kissed by Death II.", and the Air Rescue Series - "The Two Sisters of Kuwait", and the soon to be released in 2010